4.7 Article

KMT2D regulates specific programs in heart development via histone H3 lysine 4 di-methylation

期刊

DEVELOPMENT
卷 143, 期 5, 页码 810-821

出版社

COMPANY OF BIOLOGISTS LTD
DOI: 10.1242/dev.132688

关键词

KMT2D; MLL2; MLL4; ALR; Kabuki syndrome; H3K4 methylation; Heart development; Mouse

资金

  1. Agency of Science, Technology and Research Singapore (A*STAR)
  2. Intramural Research Program of the National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  3. NIH/National Heart, Lung, and Blood Institute (NHLBI) [NHLBI Bench to Bassinet Program] [U01HL098179/UM1HL098179]
  4. Lawrence J. and Florence A. DeGeorge Charitable Trust/American Heart Association Established Investigator Award, an NIH/National Center for Research Resources (NCRR) grant [C06 RR018928]

向作者/读者索取更多资源

KMT2D, which encodes a histone H3K4 methyltransferase, has been implicated in human congenital heart disease in the context of Kabuki syndrome. However, its role in heart development is not understood. Here, we demonstrate a requirement for KMT2D in cardiac precursors and cardiomyocytes during cardiogenesis in mice. Gene expression analysis revealed downregulation of ion transport and cell cycle genes, leading to altered calcium handling and cell cycle defects. We further determined that myocardial Kmt2d deletion led to decreased H3K4me1 and H3K4me2 at enhancers and promoters. Finally, we identified KMT2D-bound regions in cardiomyocytes, of which a subset was associated with decreased gene expression and decreased H3K4me2 in mutant hearts. This subset included genes related to ion transport, hypoxia-reoxygenation and cell cycle regulation, suggesting that KMT2D is important for these processes. Our findings indicate that KMT2D is essential for regulating cardiac gene expression during heart development primarily via H3K4 di-methylation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据